Search Browse Earnings

CollPlant Biotechnologies Ltd

Nasdaq:CLGN

Orthopedic, Prosthetic & Surgical Appliances & Supplies·REHOVOT, L3

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CollPlant Biotechnologies Ltd — SlamSEC

Revenue

$299,000

-98.1% YoY

FY 2024

Adj. EBITDA

-$16.0M

-5358.2% margin

FY 2024

Net Income

-$16.9M

-5660.5% margin

FY 2024

EPS (Diluted)

-$1.53

FY 2024

Stock Price

$0.60

+0.0%

2026-03-19

52W Range

$0.49 – $4.98

P/E Ratio

-0.4x

Market Cap

$6.9M

Cash

$26.7M

FY 2024

Total Debt

$2.2M

FY 2021

Net Cash

$24.5M

FY 2021

Enterprise Value

-$17.6M

Debt / EBITDA

1.5x

FY 2024

EV / EBITDA

1.1x

Employees

—